Disease Connection Answers May Exist within this Arizona Tribe

Recent studies are uncovering how diabetes may structurally alter the brain, leading to cognitive decline.

3:30 PM

Author | Eva Feldman, M.D., Ph.D.

Group of medical professionals outside

The Pima Indians, an American Indian tribe in southern Arizona, may hold a key to understanding the relationship between diabetes and Alzheimer's disease, two diseases rapidly increasing in the United States.

Diabetes affects 30 million Americans, with an additional 84 million Americans having prediabetes. The disease is known to cause nerve damage in limbs and damage to kidneys, the eyes and other organs.

Eva L. Feldman, M.D., Ph.D., the director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine, is working with Robert Nelson, M.D., at the National Institute of Diabetes and Digestive and Kidney Diseases, located in Phoenix, to study these conditions. Dr. Nelson has spent his academic career understanding diabetes and its complications in the Pima Indians.

Recent studies are beginning to uncover how diabetes may structurally alter the brain, and increase the risk of cognitive decline and dementia, including Alzheimer's disease. Over 5.8 million Americans suffer from Alzheimer's disease, which robs people of their mental capabilities. As the U.S. population ages, the number of people with Alzheimer's disease is predicted to reach 14 million by 2050.

SEE ALSO: 4 Takeaways from 'The Lancet' Report on Alzheimer's Disease Burden

"We're looking into the phenomenon of cognitive decline in the Pima population," says Feldman, who is also the Russell N. DeJong Professor of Neurology at U-M.

"In their most recent visits, members of the tribe are volunteering to undergo magnetic resonance imaging of their brain. We are also assessing functional cognition. Once all these data are collected on the brain, we will determine whether any correlations exist between brain abnormalities and diabetes and obesity. We suspect that we will find associations between worsening cognitive decline and abnormal brain structural changes and diabetes and greater obesity."

LISTEN UP: Add the Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher.

The Pima Indians participated in one of the longest running diabetes studies, dating back 50 years. The Lancet reported in 1971 that diabetes is almost a way of life for the Pima, where type 2 diabetes and obesity are highly prevalent and occur at a younger age than in the general population. Although the main study ended in 2007, today, Pima Indians continue to participate in several studies of diabetes and its complications.

Thanks to their continued participation, the scientific community has gained insights into the relationship between metabolic dysfunction and brain structure and function, Feldman says.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"For instance, we found that neuropathy was more prevalent in diabetic patients who were also obese," says Feldman. "Moreover, Pima patients with cardiac autonomic neuropathy are also more likely to have kidney disease. Most recently, we found a correlation between the presence of specific types of fats in the blood and the risk of kidney disease. These studies help us identify at-risk patients."

Feldman and Nelson also counsel study participants on dietary habits that could help them prevent some of these complications.

SEE ALSO: Does Exercise Affect the Brain's Aging Process? U-M Research Aims to Find Out

"These studies are truly underscoring the importance of a healthy, balanced diet," says Feldman. "It's not enough to control glucose levels as previously thought. Patients need a more thorough approach and they need to do it early on, or they could be facing issues further on in life."

Currently, Feldman and Nelson are investigating how diabetes and obesity can affect brain health. "We have discovered that obesity correlates with a decreased size in selected brain areas, as measured by magnetic resonance imaging (MRI)." They are presenting these new findings at the American Diabetes Association in Chicago this June. "These new discoveries continue to emphasize how important diet and exercise are to nervous system health," states Feldman.


More Articles About:

Body Work Diabetes Counseling Diabetes Education Diabetes Management Diabetes Support Type 1 Diabetes type 2 diabetes Wound Care Alzheimer's Disease Neurodegenerative Disorder Neuropathy & Peripheral Nerve Disorders Diabetes
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Minding memory above a microphone on a blue background
Minding Memory

Can Your Voice Reveal Early Signs of Alzheimer’s?

In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.
Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

The Care Ecosystem: Supporting People Living with Dementia and Their Families

Welcome back to Season 6 of Minding Memory! In this episode, Lauren & Matt speak with Dr. Katherine (Kate) Possin, who holds the John Douglas French Alzheimer’s Foundation Professorship at the University of California, San Francisco Fein Memory & Aging Center. Dr. Possin talks about the Care Ecosystem, a telephone and web-based model that provides ongoing education, support, care planning, and coordination for people living with dementia and their care partners. They’ll dig into how the Care Ecosystem was developed, and what studies have shown about its impact on people living with dementia.